THRIVE

Serial Number 98579402
Registration 7814609
700

Registration Progress

Application Filed
May 31, 2024
Under Examination
Approved for Publication
Apr 15, 2025
Published for Opposition
Apr 15, 2025
Registered
Jun 3, 2025

Trademark Image

THRIVE

Basic Information

Serial Number
98579402
Registration Number
7814609
Filing Date
May 31, 2024
Registration Date
June 3, 2025
Published for Opposition
April 15, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 3, 2025
Registration
Registered
Classes
042

Rights Holder

Affini-T Therapeutics, Inc.

03
Address
100 Forge Road, Suite 900
Watertown, MA 02472

Ownership History

Affini-T Therapeutics, Inc.

Original Applicant
03
Watertown, MA

Affini-T Therapeutics, Inc.

Owner at Publication
03
Watertown, MA

Affini-T Therapeutics, Inc.

Original Registrant
03
Watertown, MA

Legal Representation

Attorney
Theodore J. Bielen, Jr.

USPTO Deadlines

Next Deadline
1949 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250603)
Due Date
June 03, 2031
Grace Period Ends
December 03, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

15 events
Date Code Type Description Documents
Jun 3, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 3, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 15, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 15, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 9, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 21, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 14, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 14, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 14, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 17, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 17, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 17, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 16, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 14, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 31, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Research and development in the field of genetically modified cells, namely research and development of manufacturing processes for the production of fit and proliferative T-cells exhibiting naive and stem cell memory phenotypes through gene editing and cell therapy manufacturing for the treatment of patients having solid tumors by eradicating metastatic cells
First Use Anywhere: Jun 27, 2023
First Use in Commerce: Jun 27, 2023

Classification

International Classes
042